Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma

NCT02831933 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Lung Squamous Cell Carcinoma Stage IV
Nonsquamous Nonsmall Cell Neoplasm of Lung
Metastatic Uveal Melanoma

Interventions

BIOLOGICAL: ADV/HSV-tk
DRUG: Valacyclovir
RADIATION: SBRT
DRUG: nivolumab

Sponsor

Eric Bernicker, MD